Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma

Por Yeddula, Narayana, Xia, Yifeng, Ke, Eugene, Beumer, Joep, Verma, Inder M.
Publicado no Proc Natl Acad Sci U S A (2015)

Reduced cell proliferation by IKK2 depletion in a mouse lung cancer model

Por Xia, Yifeng, Yeddula, Narayana, Leblanc, Mathias, Ke, Eugene, Zhang, Yonghui, Oldfield, Eric, Shaw, Reuben J., Verma, Inder M.
Publicado em 2012

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin

Por Xia, Yifeng, Liu, Yi-Liang, Xie, Yonghua, Zhu, Wei, Guerra, Francisco, Shen, Shen, Yeddula, Narayana, Fischer, Wolfgang, Low, William, Zhou, Xiaoying, Zhang, Yonghui, Oldfield, Eric, Verma, Inder M.
Publicado no Sci Transl Med (2014)